Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

The therapy takes the form of stem cell-derived human pancreatic ... The first trials are taking place with “naked” cells in people with type 1 diabetes, according to Vertex chief executive ...

Q: My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, ...

A Japanese hospital said Monday it has completed a clinical test to transplant induced pluripotent stem cells that produce insulin to treat a patient with type 1 diabetes, in a step that could ease ...

Over the last two and a half decades, advancements in stem cell biology and immunology have improved the potential for cell therapy as a treatment for diabetes. Stem cells from ... programmed cell ...

Kyoto University Hospital says it has started clinical trials to transplant cells created from induced pluripotent stem cells into type one diabetes patients.

KYOTO—Kyoto University Hospital officials announced on April 14 that a research team conducted a clinical trial in ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

"This suggests that humans also have a narrow window of colonization by these beta cell promoting microbes," said Hill. When male mice that were genetically predisposed to Type 1 diabetes were ...

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...